Merck & Co., Inc. (NYSE: MRK) is recovering from the virus-induced slowdown supported by stable demand across its product line globally, a
Is Merck & Co. (MRK) a good investment after Q1 earnings?
Categories
Health Care
Cronos Group Inc. (CRON) Q1 2022 Earnings Call Transcript
Cronos Group Inc. (NASDAQ: CRON) Q1 2022 earnings call dated May. 10, 2022 Corporate Participants: Shayne J. Laidlaw -- Director of Investor Relations and
ANI Pharmaceuticals Inc. (ANIP) Q1 2022 Earnings Call Transcript
ANI Pharmaceuticals Inc. (NASDAQ: ANIP) Q1 2022 earnings call dated May. 10, 2022 Corporate Participants: Lisa Wilson -- Investor Relations Nikhil Lalwani -- President & Chief
BioLife Solutions Inc. (BLFS) Q1 2022 Earnings Call Transcript
BioLife Solutions Inc. (NASDAQ: BLFS) Q1 2022 earnings call dated May. 09, 2022 Corporate Participants: Troy Wichterman -- Chief Financial Officer Michael Rice -- Chairman &
TRxADE HEALTH Inc. (MEDS) Q1 2022 Earnings Call Transcript
TRxADE HEALTH Inc. (NASDAQ: MEDS) Q1 2022 earnings call dated May. 09, 2022 Corporate Participants: Janet Huffman -- Chief Financial Officer Suren Ajjarapu -- Founder, Chairman
Cara Therapeutics Inc. (CARA) Q1 2022 Earnings Call Transcript
Cara Therapeutics Inc. (NASDAQ: CARA) Q1 2022 earnings call dated May. 09, 2022 Corporate Participants: Iris Francesconi -- Interim Head of Investor Relations Christopher
Petmed Express Inc. (PETS) Q4 2022 Earnings Call Transcript
Petmed Express Inc. (NASDAQ: PETS) Q4 2022 earnings call dated May. 09, 2022 Corporate Participants: Bruce S. Rosenbloom -- Chief Financial Officer and Treasurer
Infographic: Highlights of Merck’s (MRK) Q1 2022 earnings
Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than-expected earnings and revenues for the first quarter of 2022. The positive outcome
ImmunoGen, Inc. (IMGN) Q1 2022 Earnings Call Transcript
ImmunoGen, Inc. (NASDAQ: IMGN) Q1 2022 earnings call dated May. 06, 2022 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications Mark Enyedy -- President
Cigna Corporation (CI) Q1 2022 Earnings Call Transcript
Cigna Corporation (NYSE: CI) Q1 2022 earnings call dated May. 06, 2022 Corporate Participants: Ralph Giacobbe -- Senior Vice President, Investor Relations David Cordani -- Chairman
Illumina Inc. (ILMN) Q1 2022 Earnings Call Transcript
Illumina Inc. (NASDAQ: ILMN) Q1 2022 earnings call dated May. 05, 2022 Corporate Participants: Salli Schwartz -- Vice President, Investor Relations Sam Samad -- Chief Financial
CVS Health (CVS) is a great stock to buy this year. Here’s why
CVS Health Corporation (NYSE: CVS), a diversified health services company, made an impressive start to the year after ending 2021 on a
Cardinal Health Inc. (CAH) Q3 2022 Earnings Call Transcript
Cardinal Health Inc. (NYSE: CAH) Q3 2022 earnings call dated May. 05, 2022 Corporate Participants: Kevin Moran -- Vice President, Investor Relations Mike Kaufmann -- Chief
Biogen’s (BIIB) long-term prospects look intact despite Alzheimer’s drug setback
Biogen Inc. (NASDAQ: BIIB) is currently going through a difficult phase as the biotechnology firm’s main products face stiff competition and the
PetIQ Inc. (PETQ) Q1 2022 Earnings Call Transcript
PetIQ Inc. (NASDAQ: PETQ) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Katie Turner -- Investor Relations McCord Christensen -- Chief Executive Officer and
Jazz Pharmaceuticals PLC (JAZZ) Q1 2022 Earnings Call Transcript
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Andrea N. Flynn -- Vice President, Head, Investor Relations
10X Genomics Inc. (TXG) Q1 2022 Earnings Call Transcript
10X Genomics Inc. (NASDAQ: TXG) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Cassie Corneau -- Manager, Investor Relations & Strategic Finance
CVS Health Corporation (CVS) Q1 2022 Earnings Call Transcript
CVS Health Corporation (NYSE: CVS) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Tom Cowhey -- Senior Vice President, Capital Markets Karen
Regeneron Pharmaceuticals Inc. (REGN) Q1 2022 Earnings Call Transcript
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Ryan Crowe -- Vice President of Investor Relations Leonard
Moderna Inc. (MRNA) Q1 2022 Earnings Call Transcript
Moderna Inc. (NASDAQ: MRNA) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Lavina Talukdar -- Senior Vice President and Head of Investor
CVS Health Earnings Q1 2022: Here are the key highlights from the results
CVS Health (NYSE: CVS) reported first quarter 2022 earnings results today. Total revenues for the quarter increased to $76.8 billion, up 11.2%